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Abstract 
Biliary complications often lead to acute and
chronic liver injury after orthotopic liver trans-
plantation (OLT). Bile composition and secre-
tion depend on the integrated action of all the
components of the biliary tree, starting from
hepatocytes. Fatty livers are often discarded as
grafts for OLT, since they are extremely vulner-
able  to  conventional  cold  storage  (CS).
However, the insufficiency of donors has stim-
ulated research to improve the usage of such
marginal organs as well as grafts. Our group
has  recently  developed  a  machine  perfusion
system  at  subnormothermic  temperature
(20°C; MP20) that allows a marked improve-
ment in preservation of fatty and even of nor-
mal rat livers as compared with CS. We sought
to evaluate the response of the biliary tree of
fatty liver to MP20, and a suitable marker was
essential to this purpose. Alkaline phosphatase
(AlkP, EC 3.1.3.1), frequently used as marker of
membrane transport in hepatocytes and bile
ducts,  was  our  first  choice.  Since  no  histo-
chemical data were available on AlkP distribu-
tion and activity in fatty liver, we have first set-
tled to investigate AlkP activity in the steatotic
liver of fatty Zucker rats (fa/fa), using as con-
trols  lean  Zucker  (fa/+)  and  normal  Wistar
rats. The AlkP reaction in Wistar rats was in
accordance with the existing data and, in par-
ticular, was present in bile canaliculi of hepa-
tocytes in the periportal region and midzone,
in the canals of Hering and in small bile ducts
but not in large bile ducts. In lean ZR liver the
AlkP reaction in Hering canals and small bile
ducts was similar to Wistar rat liver but hepa-
tocytes  had  lower  canalicular  activity  and
besides presented moderate basolateral reac-
tion. The difference between lean Zucker and
Wistar  rats,  both  phenotypically  normal  ani-
mals,  could  be  related  to  the  fact  that  lean
Zucker rats are genotypically heterozygous for
a recessive mutated allele. In fatty liver, the
activity in ductules and small bile ducts was
unchanged, but most hepatocytes were devoid
of AlkP activity with the exception of clusters
of macrosteatotic hepatocytes in the mid-zone,
where the reaction was intense in basolateral
domains and in distorted canaliculi, a typical
pattern  of  cholestasis.  The  interpretation  of
these data was hindered by the fact that the
physiological role of AlkP is still under debate.
In the present study, the various functions pro-
posed for the role of the enzyme in bile canali-
culi  and  in  cholangiocytes  are  reviewed.
Independently of the AlkP role, our data sug-
gest that AlkP does not seem to be a reliable
marker to study the initial step of bile produc-
tion during OLT of fatty livers, but may still be
used to investigate the behaviour of bile duc-
tules and small bile ducts.
Introduction
The increased demand of organs for ortho-
topic liver transplantation (OLT) has stimulat-
ed the research of strategies to increase the
pool of donors by including the so-called mar-
ginal  organs,  especially  fatty  livers.  Liver
steatosis,  which  is  frequently  observed  in
potential  donors,  has  been  considered  an
important risk factor for injury caused by con-
ventional cold storage with a higher incidence
of  postoperative  primary  non-function  and
poor  initial  function  of  the  graft,  and  lower
patient and graft survival.1-3 As a matter of fact,
steatotic  livers  are  more  susceptible  to
ischemia/reperfusion injury after transplanta-
tion,  with  loss  of  viability  of  sinusoidal
endothelial  cells,  sinusoidal  congestion  and
rupture of hepatocytes releasing fat droplets,
causing microcirculatory failure.4-8
Biliary  complications  are  considered  the
Achilles’ heel of liver transplantation because
of their frequency and potential lethal effect on
the survival of both graft and patient.9-11 These
complications are a major cause of morbidity
and  graft  failure  in  patients  after  OLT  and
include  a  wide  spectrum  of  functional  and
anatomical abnormalities, such as bile leakage
and  large  biliary  duct  strictures;  their  inci-
dence is estimated to be 8-20% and may lead to
acute  and  chronic  liver  injury.2-14 The  fast
restoration of biliary secretion is an important
index  of  hepatic  functional  restoration  after
preservation by cold ischemic storage (CS),15
and bile analysis is a useful tool to assess the
integrity  of  biliary  epithelial  cells  after  cold
ischemia/reperfusion of rat liver.16 The forma-
tion of bile depends on the structural and func-
tional  integrity  of  the  biliary  tree  and  its
impairment  results  in  the  syndrome  of
cholestasis. 
Experimental and clinical studies have indi-
cated that bile formation early after liver trans-
plantation may be disturbed, resulting in more
cytotoxic  bile  with  a  relatively  low  phospho-
lipids/bile  salt  ratio.7 A  close  relationship
between this ratio early after liver transplanta-
tion and injury of the small bile ducts in the
liver has been found,18 supporting the hypoth-
esis  that  early  changes  in  bile  composition
contribute to the relatively late stricturing of
the large bile ducts.14 This data suggest that
the  different  cell  types  of  the  biliary  tree
(hepatocytes, transition cells of Hering canals
and  cholangiocytes  in  small  and  large  bile
ducts) play different roles in the progressive
post-transplantation injury phases to the bil-
iary tract. 
The analysis of the biliary tree behaviour
towards  transplantation  has  however  lagged
behind  studies  concerning  hepatocytes  and
sinusoidal  cells,  even  though  bile  canaliculi
are one of the liver structures that are dam-
aged  markedly  and  early  during  ischemia-
reperfusion occurring in patients undergoing
OLT.19 Furthermore, the damage to bile duct
cells is important in the long-lasting phase of
reperfusion injury,20 the recovery of the biliary
tree  from  preservation  injury  takes  longer
compared  with  hepatocytes  or  endothelial
cells21 and regeneration of its cellular ATP is
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much slower than in hepatocytes.22Even less is
known, to the best of our knowledge, on the
behaviour of the biliary structures of fatty liv-
ers respect to OLT. 
Most animal studies showing increased sus-
ceptibility or decreased tolerance of fatty livers
to injury have been conducted in genetically
obese rodents such as the obese Zucker rat
(ZR).23-25 The  obese  ZR  are  homozygous  for
non-functional leptin receptors (fa/fa);26 they
thus  cannot  respond  to  the  satiety  stimulus
and  became  hyperphagic,  obese,  hyperinsu-
linemic  (insulin-resistant),  but  have  normal
blood glucose levels and do not develop dia-
betes.24 The lean ZR that are heterozygous for
the allele fa (fa/+) maintain a lean phenotype
throughout life with normal blood insulin and
glucose levels. 
Our group has recently developed a machine
perfusion  (MP)  system  at  subnormothermic
temperature, 20°C (MP20) with a low-viscosity
perfusion medium based on Krebs-Henseleit
buffer  and  containing  N-acetylcysteine,  glu-
cose  and  low  concentration  of  calcium,  that
appears as a promising strategy to protect the
liver of normal rats (Wistar, lean Zucker) and
fatty liver (FL) of obese ZR performing bio-
chemical,  histochemical  and  ultrastuctural
analyses.27,28 In particular, we have shown that,
compared with traditional cold storage, MP20
leads to FL preservation in terms of enzyme
release  into  the  perfusate  and  bile,  energy
charge,  glycogen  stores  and  reactive  oxygen
species  production.28 Histochemical  analyses
revealed that MP20 caused a marked reduction
of steatosis through ketogenesis (preliminary
results)29 and of parenchymal and sinusoidal
cell death by apoptosis (preliminary results).30
In order to further the research to the biliary
tract,  reliable  markers  of  the  biliary  tree  of
fatty liver were necessary. 
The  first  candidate  enzyme  was  alkaline
phosphatase  (AlkP)  (orthophosphoric-
monoester  phosphohydrolase;  EC  3.1.3.1),  a
metalloprotein bound to the outer leaflet of the
plasma  membrane  through  a  glycosylphos-
phatidylinositol  (GPI)  anchor,  markedly
expressed in the apical pole of hepatocytes and
cholangiocytes  and  secreted  in  bile  in  large
amounts31-33 that is frequently used as marker
of membrane transport in hepatocytes and bile
ducts. The determination of AlkP in the bile is
used  as  an  index  of  damage  to  cholangio-
cytes.34 Since no data were available concern-
ing this enzyme in fatty liver, we investigated
AlkP activity and its distribution in the liver of
obese ZR, frequently used as models of obesity
and  insulin-resistance.  As  controls,  we  used
either lean Zucker rats (the usual control for
obese  Zucker  rats),  heterozygous  for  the
mutated allele (fa/+) and normal Wistar rats
that do not present the mutation.
Materials and Methods
Chemicals
Unless otherwise stated, all reagents were
of the highest purity grade available and were
purchased from Sigma (Milano, Italy).
Animals
Male  Wistar  rats  (250-300g)  (Harlan-
Nossan, Corezzana, MB, Italy), 11-12 week old
obese  (fa/fa)  (375±15  g)  and  lean  (fa/+)
(300±10 g) male ZR (Charles River, Calco, LC,
Italy)  were  used.  The  animals  were  allowed
free access to water and food in all the experi-
ments. The use and care of animals in this
experimental study was approved by the Italian
Ministry  of  Health  and  by  the  University
Commission for Animal Care. Rats were anes-
thetized with sodium pentobarbital (40 mg/kg
i.p.) and received 250 U of heparin via the infe-
rior vena cava before liver uptake. 
Small tissue blocks of about 0.5 cm3 were
cut, then inserted in cryovials and snap-frozen
immediately in liquid nitrogen. Afterwards, the
material was kept at -80°C until further use.
Cryostat  sections,  8  μm  thick,  were  cut  at 
-24°C on a Leica CM 1850 cryostat.
Demonstration of alkaline 
phosphatase activity 
The indoxyl-tetrazolium salt method35,36 uti-
lizes a tissue protectant, the polyvinyl alcohol
(PVA), in order to improve the localization of
the  coloured  product  in  the  exact  zone  in
which the enzyme is present. Sections 8 μm
thick were cut on a manually-driven Leica CM
1850  cryostat  at  a  cabinet  temperature  of 
-25°C. The sections were picked up onto clean
glass slides and stored at -80°C until used.
After a 5 min drying at room temperature,
the cryosections were incubated with a medi-
um containing 18% PVA dissolved in 100 mM
Tris-HCl buffer (pH 9.0), 0.7 mM 5-bromo-4-
chloro-3-indolyl  phosphate,  0.44  mM  1-
methoxy-phenazine  methosulphate  (mPMS),
10 mM MgCl2, 5mM sodium azide and 5 mM
tetranitroblue tetrazolium (TNBT), previously
dissolved in a heated mixture of dimethylfor-
mamide and ethanol (1:1, v/v), since it is not
possible  to  dissolve  5mM  TNBT  in  aqueous
media. The final concentration of these sol-
vents  in  the  incubation  medium  was  2%.
Incubation lasted 20 min at 37°C. To stop the
reaction and to remove the incubation medium
the sections were rinsed with hot (45-50°C)
tap water and the slide mounted with glycer-
ine-jelly. Control sections were performed in
the absence of substrate.
Morphology
Samples  of  the  liver  of  obese  rats  were
quickly removed, and all small fragments were
fixed by immersion in 2.5% glutaraldehyde in
0.13 M Millonig buffer (pH 7.2-7.4) at 4°C for 
4 h, rinsed, post-fixed with 1% osmium tetrox-
ide at 4°C for 2 h, washed, dehydrated through
graded concentrations of alcohol, and embed-
ded in Epon. Semi-thin sections (1 μm thick)
were stained with 1% toluidine blue. 
Microscopy and photomicrography
The  slides  were  observed  with  Zeiss
Axioskop 2 Plus light microscope (Carl Zeiss
Microimaging, Jena, Germany) equipped with
differential interference contrast (DIC) system
and  a  Olympus  C-4040  Zoom  digital  camera
(Olympus, Tokyo, Japan) with 4 Mpixel of res-
olution. Digital images were elaborated with
Adobe Photoshop 5 (Adobe Systems Inc., San
José, CA, USA) and processed with Image Pro
Plus  4.7  image  analysis  software  (Media
Cybernetics,  Inc.,  Bethesda,  MD,  USA).  A
selective discrimination based on colour level
was performed in order to highlight with false
colour the distribution pattern of AlkP. 
Results
With  the  indoxyl-tetrazolium  salt  method,
the activity of AlkP is demonstrated by a dark
brown final reaction product. A light brown dif-
fuse staining was also observed in the controls
lacking the substrate, therefore corresponding
to non-specific reaction usually mentioned as
nothing dehydrogenase reaction (NDH).37
Wistar rat liver
In Wistar rats (Figure 1), an irregular but
strong staining was present in bile canaliculi,
especially in the periportal region but also in
the mid-zone (Figure 1a and 1b); a light diffuse
staining was seen the cytoplasm of portal hepa-
tocytes. Small bile ducts and Hering canals were
intensely coloured, but large intralobular bile
ducts, whose morphology is clearly delineated
by DIC, were negative (Figure 1a, 1c and 1d). In
Hering  canals  the  reaction  was  cytoplasmic
whereas in small bile ducts it was located main-
ly in the apical and lateral membrane domains
(Figure  1c).  Reaction  was  also  seen  in  the
adventitia  of  large  arteries,  but  not  of  small
ones (Figure 1a).
Lean Zucker rat liver
Respect  to  Wistar  rat  liver,  differences  in
reactivity  were  noticed  only  in  hepatocytes
(Figure 2). Namely, staining was less intense
and present not only in bile canaliculi but also
Original paper[page 26] [European Journal of Histochemistry 2011; 55:e5]
in the basolateral membrane domains (Figure
2 a,b,c). As in Wistar rat liver, the AlkP activity
was very strong in bile ductules but negative in
larger bile ducts (Figure 2a).
Obese Zucker rat liver
In small and large bile ducts the AlkP distri-
bution pattern in this animal model of obesity
was similar to that seen in lean ZR and Wistar
rats (Figure 3a and inset). Marked differences
were  observed  in  hepatocytes.  In  particular,
hepatocytes in the periportal area were nega-
tive whereas macrosteatotic hepatocytes in the
mid-zone displayed intense staining in canali-
culi  and  moderate  staining  in  basolateral
membrane domains (Figure 3b). The mid-zone
was furthermore characterized by moderately
intense NDH reaction. The typical morphology
of  macro-and  microsteatotic  hepatocytes  is
shown in Figure 3c.
A better appraisal of the differences in sub-
cellular distribution of AlkP activity in hepato-
cytes  of  Wistar,  lean  and  obese  ZR  liver  is
shown in Figure 3 d-f, where the most intense
levels  of  AlkP  are  evidenced  by  a  blue  false
colour by means of image analysis. 
Discussion
The  biliary  tree,  considered  the  Achilles’
heel of liver transplantation9 is morphological-
ly and functionally heterogeneous.38,39 The pri-
mary bile is secreted by hepatocytes into bile
canaliculi, which drain into canals of Hering at
the ductular-hepatocellular junction, lined in
part by hepatocytes and in part by cholangio-
cytes. In the rat, Hering canals are in direct
flow with small bile ducts (lined by cuboidal
cells) that in turn empty into large bile ducts
(lined by columnar cells).38,40 Cholangiocytes
play an important role in water and electrolyte
secretion, modulating canalicular bile through
a sequence of both secretory and absorptive
processes  aimed  at  adjusting  bile  flow  and
alkalinity to the physiological needs.38,39
Three mechanisms contributing to bile duct
injury  after  liver  transplantation  have  been
postulated:  injury  due  to  preservation  or
ischemia/reperfusion, immunological process-
es and injury induced by cytotoxicity of biliary
bile salts.11,14,18 Bile salts are potent detergents
that may damage cells by affecting the integri-
ty  of  cellular  membranes,  in  particular  by
extracting phospholipids and cholesterol from
membranes to form micelles.41 Normally, these
toxic effects are prevented by neutralization of
bile salts by phospholipids and the formation of
mixed  micelles  in  bile.  Phospho  lipids  are
secreted into bile in human via the concerted
action  of  canalicular  multidrug  resistance-3
(MDR3)  P-glycoprotein  and  canalicular  bile
salts.17
Steatotic liver, increasingly frequent among
potential liver grafts for OLT, is often discard-
ed, since its response to conventional cold stor-
age is very poor.3 Our group has recently devel-
oped  an  alternative  preservation  modality,
based on machine perfusion at subnormother-
mic  temperature  (20°C;  MP20)  that  has
revealed a high potential for the preservation
of normal and fatty livers.27,28,42 Besides inves-
tigating with a histochemical approach various
parameters  related  to  the  metabolism  and
injury of parenchymal and sinusoidal cells of
livers submitted to MP2028,29 we sought to doc-
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Figure  1.  Photomicrographs  of  histochemical  demonstration  of  alkaline  phosphatase
activity in Wistar rat liver (differential interference contrast; DIC); (a) Survey view of the
portal area. The reaction is very intense in small bile ducts (d), Hering’s canals (H), tuni-
ca externa (adventitia) of large arteries (A) but not in arteriole (a) and in several bile
canaliculi identified mostly longitudinally but also transversally (black arrows). In the
lumen of one of the large arteries a positive granulocyte can be seen. P: portal vein
branch. Scale bar = 50 µm; (b) Typical chicken-wire pattern of bile canaliculi (black
arrows) in the portal area (see also Figure 3d). Scale bar = 50 µm; (c) Detail of AlkP activ-
ity in bile ductule (d) and Hering’s canals (H) seen under higher magnification. Scale bar
= 25 µm; (d) Closer view of bile ductule (d) confluence into a larger bile duct (D) Scale
bar = 25 µm.[European Journal of Histochemistry 2011; 55:e5] [page 27]
ument the response of the biliary tree using
the most frequently used functional marker of
biliary structures and integrity, alkaline phos-
phatase. Since no data were available we made
a preliminary study, here reported, to describe
its distribution and activity in fatty liver, taking
normal Wistar rat liver and lean ZR liver as
controls.
Wistar rat liver
The distribution of AlkP in Wistar rat liver is
in keeping with the histochemical literature
on the enzyme, independently of the method
used for its visualization, that is the indoxyl-
tetrazolium salt method used in the present
research,35,43,44the metal capture method or the
simultaneous coupling method.36,37,45 However,
as far as large bile ducts are concerned, our
data  disagree  with  data  reported  on
reviews,38,46 according to which in the rat AlkP
is expressed by large interlobular bile ducts
but  not  by  small  bile  ducts.  In  particular,  a
research  showing  that  exogenous  alkaline
phosphatase was able to inhibit secretin-stim-
ulated ductal secretion by blocking cystic fibro-
sis transmembrane regulator (CFTR) channels
expressed only in large ducts,47 was said to be
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Figure 2. Alkaline phosphatase activity in lean Zucker rat liver. (a) Survey of a portal
region showing several intensely stained bile ductules (d) which abut into on a large duct
(D), negative for AlkP. Moderately intense staining is present not only in bile canaliculi
(black  arrows)  but  also  in  basolateral  (interhepatocyte)  membrane  domains  (white
arrows). The white arrow heads indicate positive sinusoidal cells. (a)=arteriole. (DIC);
(b) and (c) Details of AlkP staining in interhepatocyte membrane domains (white arrows)
and bile canaliculi (black arrows) (bright field) (see also Figure 3e). Scale bar = 50 µm.
Figure 3. Alkaline phosphatase activity in obese Zucker rat liver and comparison among the
highest levels of AlkP activity in Wistar, lean and obese Zucker rat hepatocytes. (a) Detail of
a portal region of obese Zucker rat liver showing a strong reaction in bile ductules (d) conflu-
ent on a negative large bile duct (D) (see also inset). Hepatocytes are negative for the AlkP
reaction. A: large artery (the void arrow head indicates fibroblasts in the adventitia, moder-
ately positive for the reaction); a: small artery; P: branch of portal vein. DIC. Scale bar = 50
µm; (b) Detail of a macrosteatotic area of obese Zucker rat liver (black asterisks) in the mid-
zone characterized by strong AlkP reaction in canalicular (black arrows) and less intense
staining in basolateral domains (white arrows); elsewhere the reaction in hepatocytes is neg-
ative  (see  also  Figure  3f.  CL:  centrolobular  vein.  Bright  field.  Scale  bar  =  50  µm;  (c)
Representative light photograph of a semithin section of obese Zucker rat stained with
Toluidine Blue. Both microsteatotic (white asterisks) and macrosteatotic (black asterisks)
hepatocytes can be identified; the bluish color of droplets indicates the presence of unsaturat-
ed lipids (fixed by osmium tetroxide) whereas most unstained small droplets contained satu-
rated fat, that having not being fixed by osmium tetroxide has been extracted during the
inclusion process. Unsaturated lipid is thus abundant in macrosteatotic cells. Bright field.
Scale bar = 25 µm; (d) Wistar rat liver: Intense canalicular AlkP activity, highlighted in blue,
is present in hepatocytes in the periportal and mid-zone regions. Bright field and image
analysis. Scale bar = 25 µm; (e) Lean Zucker rat liver: the reaction is seen both in interhepa-
tocyte and canalicular domains in the periportal area and mid-zone. A small bile duct with
intense activity parallel to a branch of the portal vein (P) is also evidenced. CL: centrolobu-
lar vein. Scale bar = 25 µm; (f) Obese Zucker rat liver: Macrosteatotic hepatocytes in the mid-
zone region show intense AlkP activity, in canalicular and interhepatocyte domains. CL: cen-
trolobular vein. Scale bar = 25 µm.[page 28] [European Journal of Histochemistry 2011; 55:e5]
in keeping with the expression of AlkP in large
but not small ducts.46 However, Alvaro et al.,47
who  used  the  same  enzyme  histochemical
method  we  did,  reported  AlkP  activity  along
bile canaliculi in the periportal region and in
cholangiocytes,  without  mentioning  which
ducts and showing a photograph at low magni-
fication, where the morphology of the stained
bile  structures  cannot  be  evaluated.  On  the
other hand, and as demonstrated herein, the
observation of sections from all the three ani-
mal  models  under  differential  interference
contrast never showed AlkP activity in cholan-
giocytes nor in the lumen of large ducts, but
only in bile ductules and Hering canals. We
suggest  that  what  could  be  interpreted  by
Alvaro et al.,47 as basal activity in large ducts
when  sections  were  observed  under  bright
field and low magnification, was in reality the
reaction present in small bile ducts or Hering
canals that form a marked plexus around the
portal canal.48 The best choice for analysing
unstained structures is indeed DIC.
Staining for AlkP activity of the adventitia of
large arteries is in accordance with observa-
tions made on rat myocardium with the metal
capture method and with antibodies against
rat liver AlkP.49 The absence of staining in the
sinusoidal endothelial cells has as well been
reported  before.50 It  is  worth  recalling  that
whereas human liver AlkP activity occurs in
the sinusoid and, to a lesser extent, biliary pole
of hepatocytes,51 in rat liver activity is mainly
localized in the canalicular membrane of hepa-
tocytes and in portal triad blood vessels.52
Lean Zucker rat liver
Respect to Wistar rat liver, a significant dif-
ference  in  intracellular  AlkP  activity  in  lean
Zucker  rat  liver  was  seen  in  hepatocytes,
whereas similar patterns and reaction intensi-
ty were seen in the other segments of the bil-
iary tree. As a matter of fact, hepatocytes in
lean ZR displayed AlkP activity not only in bile
canaliculi  but  also  (though  less  intense
respect to obese rat liver) in basolateral mem-
brane domains. 
Obese Zucker rat liver
Respect to Wistar and lean ZR, in the obese
rat liver the differences of AlkP activity were
once more seen only at the hepatocyte level. In
fatty  liver,  portal  hepatocytes  were  negative
whereas the most steatotic cells in the mid-
zone had intense lateral membrane staining
and only occasionally canalicular activity, dis-
torted by fat droplets. 
In order to correlate the differences in AlkP
activity in hepatocytes to metabolic features of
the three animal models it would have been
helpful to know the physiological role of AlkP
and the nature of its natural substrate in hepa-
tocytes  and  cholangiocytes.  Unfortunately,
these remain controversial, although AlkP has
been routinely applied as a marker for liver
function for over 70 years.37,53,54 In particular,
the function and role of AlkP in the progres-
sion  of  cholestatic  diseases  are  virtually
unknown.47
In the following we review and discuss sev-
eral alternative proposals for AlkP function.
Phosphorylcholine hydrolysis
Pekarthy et al.55 suggested that at least one
of the functions of canalicular AlkP in hepato-
cytes  was  to  hydrolyze  phosphorylcholine  so
that choline could be transported across the
bile  canalicular  membrane;    this  hypothesis
was later questioned by studies showing that
purified rat liver alkaline phosphatase had no
particular  affinity  for  phosphorylcholine  and
that it could act instead in general as a non-
specific  ATPase.31 However,  the  speculation
that AlkP might be involved in choline trans-
port across cell membranes is still being put
forth.56 This hypothesis could be relevant for
the  turnover  of  biliary  phosphatidyl  choline
that may be degraded in bile by phospholipase
C to phosphorylcholine and diacylglycerol.57 By
catalysing  the  subsequent  removal  of  phos-
phate from phosphorylcholine, alkaline phos-
phatase  of  hepatocytes  would  contribute  to
reabsorption  of  choline  from  bile.58 To  our
knowledge,  no  choline  reabsorption  in  bile
ducts has been reported.
Choline is an essential nutrient needed for
the structural integrity and signaling functions
of cell membranes; for normal cholinergic neu-
rotransmission;  for  normal  muscle  function;
for lipid transport from liver; it is the major
source of methyl groups in the diet, a choline
deprived diet may induce steatosis of the liver
and eventually cause hepatocarcinogenesis.59
As far as membranes are concerned, choline is
required for the biosynthesis of phosphatidyl-
choline, sphingomyelin and choline plasmalo-
gens. The concentration of sphingomyelin is
higher in the canalicular domain of hepato-
cytes plasma membrane respect to the sinu-
soidal  domain.60 Within  the  canalicular
domain, sphingolipids are particularly concen-
trated in lipid rafts.61 Plasmalogens have a rel-
atively low concentration in the liver, but are
known  to  be  present  mainly  associated  to
sphingolipids in lipid rafts.62
Non-specific ectonucleotidases
Earlier  studies  suggested  that  AlkP  might
act as an ecto-phosphatase regulating extra-
cellular  concentrations  of  phosphate  com-
pounds  such  as  pyridoxal-5’-phosphate  (the
cofactor  form  of  vitamin  B6),  phospho-
ethanolamine63 and some phosphoproteins.64
Other researches suggested that AlkP might
play an important role in the modulation of
purinergic  signalling,  that  is,  that  of  an
ectonucleotidase capable of degrading extra-
cellular ATP (or its derivatives ADP and AMP)
to  adenosine.31,47,65-67 Alkaline  phosphatases
remove phosphate groups in the 5’ and 3’ posi-
tions from several types of molecules including
nucleotides.66 Extracellular nucleotides and, in
particular,  ATP,  act  as  important  autocrine/
paracrine  signalling  molecules  regulating
hepatobiliary  functions  such  as  hepatocyte
glycogen metabolism, cell volume, bile forma-
tion, and other cell functions. These effects are
mediated by the activation of purinergic recep-
tors. Hepatocytes release ATP in venous blood
and in the bile, and cholangiocytes secrete ATP
in the bile.68 Purinergic receptors have been
identified in the plasma membrane of hepato-
cytes and cholangiocytes; their activation con-
tributes to the regulation of metabolism, ion
channel  activation,  coordination  within  the
liver lobule of cell-to-cell Ca2+ signalling, cell
volume regulation, secretion, and coupling of
the  separate  hepatocyte  and  cholangiocyte
contributions to bile formation.68,69Nucleotides
released in the extracellular space are rapidly
inactivated by ectonucleotidases.70 Each liver
cell  type  expresses  its  own  repertoire  of
purinoceptor  subtypes  and  ecto-ATPases.66,71
Immunohistochemical  studies  of  ecto  ATP
diphosphohydrolase (nucleoside triphosphate
diphosphohydrolase)  performed  on  pig  liver
showed strong reactivity in the bile canaliculi
of  hepatocytes  (especially  in  the  periportal
region) in bile ducts, in the endothelium of the
portal vein and in smooth muscle cells in the
portal artery wall.72 This topological distribu-
tion colocalizes with the distribution of AlkP
activity observed in the Wistar rat liver 
Ecto- protein phosphatase 
Ecto-phosphatase  is  still  another  putative
function  for  alkaline  phosphatase.53,54 AlkP,
being  anchored  to  the  plasma  membrane,
could  dephosphorylate  soluble  cellular  sub-
strates, or cell surface proteins. Ectokinases
were shown to phosphorylate both soluble sub-
strates and membrane-bound proteins.73These
processes were though to regulate ligand bind-
ing, signal transduction and cell-to-cell intera-
tions. Both protein kinases and phosphatases
are thought to be required for reversible con-
trol of extracellular phosphorylation processes
acting in a manner similar to that in which
they  control  cytoplasmatic  phosphorylation-
dephosphorylation  systems.53,74-76 The  physio-
logical function of AlkP as an ecto-phosphatase
remains  controversial,  mainly  because  early
studies with purified AlkP describe the enzyme
as exhibiting a non-physiological alkaline pH
optimum.77 However, a pH optimum of 7-8 was
determined  for  purified  and  plasma  mem-
brane-bound human liver AlkP.53,64 It must be
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recalled that, although the main control of bile
alkalinization  is  performed  by  cholangio-
cytes,78 bicarbonate  secretion  takes  place
already at canalicular level79 and thus that the
bile pH is compatible with AlkP activity. 
The multidrug resistance-1 (MDR1) P-glyco-
protein (ABCB1; ATP-binding Cassette trans-
porter)  that  transports  cationic  and  neutral
compounds  and  steroids  out  of  cells80,81 was
specifically investigated as a possible target of
the  above  mentioned  ectophosphorylation-
dephosphorylation  processes.54,82-85 MDR1/P-
glycoprotein/ABCB1 has been reported in bile
canaliculi throughout the lobule46,79,85,86 and in
the  apical  pole  of  cholangiocytes.46,80,86,87
Membrane-bound AlkP concentration in differ-
ent tissues was shown to be positively correlat-
ed  with  the  extent  of  exchange  surface  per
unit volume of the tissue, suggesting an asso-
ciation between AlkP and transport systems.88
AlkP is located in close association with trans-
porters that play a major role in the process of
bile formation both in hepatocytes and cholan-
giocytes.47 P-glycoprotein  modulators  were
shown  to  significantly  affect  the  activity  of
hepatic-AlkP and thus the two processes seem
to be metabolically coupled.54
Modulation of endotoxin toxicity
A further and physiologically completely dif-
ferent role proposed for AlkP is defence mech-
anism  against  endotoxin  toxicity.66 Indeed
human  placental  alkaline  phosphatase
(HPLAP)  attenuates  the  lipopolysaccharide
(LPS)-mediated inflammatory response, likely
through dephosphorylation of the lipid A moi-
ety of LPS.33,89 This role could contribute to the
defence of the biliary tract against sepsis.
The  above  reviewed  diversified  functions
proposed for AlkP might not be incompatible,
but instead refer to different anatomic loca-
tions within the biliary tree.
Discussion of histochemical 
patterns in terms of the putative
functions of alkaline phosphatase
The  non-specific  light  staining  (NDH)  is
ascribed to lactate dehydrogenase activity act-
ing on endogenous lactate and nicotinamide
dinucleotide  (NAD+)  and/or  to  endogenous
thiol groups of glutathione, cysteine and other
tissue  proteins.37 The  higher  levels  of  NDH
observed in the liver of obese ZR respect to
Wistar and lean ZR are in keeping with higher
lactate dehydrogenase activity observed in the
former  (unpublished  study)  and  with  data
indicating higher concentration of lactate in
the liver of obese ZR respect to their lean con-
trols.90
The  different  behaviour  of  hepatocytes  of
lean ZR respect to Wistar rats, and in particu-
lar, the basolateral reactivity, similar to that
observed  in  macrosteatotic  hepatocytes  of
obese rats, might be a consequence of the fact
that  lean  ZR  are  phenotypically  normal but
genotypically  heterozygous  for  a  recessive
mutated allele.
The distribution of AlkP in hepatocytes of
the steatotic liver of obese rats was markedly
different  from  that  of  normal  liver.  The
absence of canalicular enzyme activity in most
hepatocytes suggests a substantial decrease in
choline reabsorption and/or decreased modula-
tion of purinergic signaling, and/or modulation
of  the  activity  of  extracellular  kinases.  As  a
matter of fact, a marked reduction of bile salt-
dependent  and  bile  salt-independent  bile
secretion  with  significant  functional  and
molecular  alterations  consistent  with  mild
cholestasis were reported in obese ZR, respect
to  lean  animals.24,41,91,92 In  particular  was
decreased the expression of some hepatocyte
transporters  such  as  the  basolateral  organic
anion  transporting  polypeptide-2  (OATP2)80
and the canalicular multidrug resistance-asso-
ciated protein 2 (MRP2/ABCC2).79,91,92 The con-
clusion of these papers, based exclusively on
biochemical determinations, was that a defec-
tive hepatobiliary transport capacity could con-
tribute to the higher susceptibility of obese ZR
to liver injury. To our knowledge, no study has
correlated AlkP activity to the activity of these
transporters. Further important characteristics
of  the  liver  of  obese  ZR  are  compromised
microcirculation that reduces the organ oxy-
genation93 and  energy  balance  (low
[ATP/ADP])  with  decreased  mitochondrial
activity respect to lean animals.90 A lower ener-
gy charge and glycogen content of obese ZR
liver respect to lean ZR was also reported by
our group.28 Therefore, ATP-dependent trans-
port across the canalicular membrane might
be impaired due to low ATP available. 
The intense AlkP activity patterns in baso-
lateral membrane domains in macrosteatotic
hepatocytes are typical of cholestasis and were
presumed to indicate the formation of extra-
canalicular sites for bile salt transport out of
the hepatocytes in conditions where bile secre-
tion is hindered.94,95In cholestasis, a strong up-
regulation of apical MDR1/ABCB1 was report-
ed,  as  a  presumed  defence  reaction  against
toxic metabolites.85,96,97
In conclusion, the absence of AlkP activity in
the canaliculi of hepatocytes of obese Zucker
rat liver indicates an impairment of processes
related to primary bile formation, extracellular
signalling modulation and/or choline reabsorp-
tion. By contrast, the processes mediated by
AlkP in bile ductules and ducts are apparently
not modified in these animals respect to nor-
mal ones. As lean ZR are concerned, the AlkP
patterns, different from those of normal Wistar
rats and are more similar to the patterns of
obese  rats,  suggest  that  the  functioning  of
their liver is not normal.
Alkaline phosphatase activity had been ini-
tially  selected  as  a  possible  marker  of  the
whole  biliary  tree  response  to  the  stresses
endured by the fatty liver during the various
phases of transplantation. This study demon-
strates  that  it  might  be  used  only  for  docu-
menting damage bile ducts.  
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